This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Cornell University. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Alyse Portnoff: Innovator in Targeted Protein Silencing
Introduction
Alyse Portnoff is a prominent inventor based in Ithaca, NY (US). She has made significant contributions to the field of biotechnology, particularly in the area of targeted protein silencing. Her innovative work has the potential to impact various therapeutic applications.
Latest Patents
Alyse Portnoff holds a patent for her invention titled "Targeted protein silencing using chimeras between antibodies and ubiquitination enzymes." This invention relates to an isolated chimeric molecule that comprises a degradation domain including a eukaryotic U-box motif and a targeting domain capable of immunospecifically directing the degradation domain to a substrate. The targeting domain is heterologous to the degradation domain, and a linker couples the two domains. The patent also discloses compositions and methods for treating diseases, substrate silencing, screening agents for therapeutic efficacy, and methods for screening disease biomarkers. She has 1 patent to her name.
Career Highlights
Alyse Portnoff is affiliated with Cornell University, where she conducts her research and development. Her work at the university has positioned her as a key figure in the advancement of biotechnological innovations.
Collaborations
Alyse has collaborated with notable colleagues, including Jeffrey Varner and Matthew DeLisa. These collaborations have further enriched her research and contributed to her innovative projects.
Conclusion
Alyse Portnoff is a trailblazer in the field of targeted protein silencing, with her patent showcasing her innovative approach to biotechnology. Her work at Cornell University and collaborations with esteemed colleagues highlight her commitment to advancing scientific knowledge and therapeutic solutions.